John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$175M |
| 2 |
Meta Platforms (Facebook)
META
|
+$163M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$138M |
| 4 |
Constellation Brands
STZ
|
+$135M |
| 5 |
Johnson & Johnson
JNJ
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$173M |
| 2 |
Pfizer
PFE
|
+$159M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$136M |
| 4 |
Dominion Energy
D
|
+$133M |
| 5 |
eBay
EBAY
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.76% |
| 2 | Consumer Discretionary | 11% |
| 3 | Industrials | 10.42% |
| 4 | Healthcare | 9.63% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
P
526
DELISTED
Pandora Media Inc
P
| $14.3M | 0.04% |
1,817,411
+1,785,682
| +5,628% | +$11.9M |
|
527
VeriSign
VRSN
$25.5B
| $14.3M | 0.04% |
103,844
+89,774
| +638% | +$11.5M |
|
528
PUT
Texas Instruments
TXN
$241B
| $14.2M | 0.04% |
128,600
+12,700
| +11% | +$1.37M |
|
|
X
529
CALL
DELISTED
US Steel
X
| $14.2M | 0.04% |
408,000
+378,000
| +1,260% | +$13.5M |
|
|
530
PUT
Dominion Energy
D
$58.6B
| $14.1M | 0.04% |
207,200
+114,300
| +123% | +$7.44M |
|
|
WRD
531
DELISTED
WildHorse Resource Development
WRD
| $14.1M | 0.04% |
556,302
+522,957
| +1,568% | +$13M |
|
532
PUT
Visa
V
$693B
| $14.1M | 0.04% |
106,500
+25,700
| +32% | +$3.31M |
|
533
Qiagen
QGEN
$9.1B
| $14.1M | 0.04% |
367,807
-472,551
| -56% | -$17.4M |
|
|
MIME
534
DELISTED
Mimecast Limited
MIME
| $14.1M | 0.04% |
341,979
+156,783
| +85% | +$6.38M |
|
535
PUT
McKesson
MCK
$100B
| $14.1M | 0.04% |
105,500
+93,500
| +779% | +$13.7M |
|
|
536
CALL
Dominion Energy
D
$58.6B
| $14M | 0.04% |
205,800
-12,000
| -6% | -$782K |
|
537
W.P. Carey
WPC
$16.2B
| $14M | 0.04% |
214,736
+102,248
| +91% | +$6.48M |
|
538
Cirrus Logic
CRUS
$5.78B
| $13.9M | 0.04% |
+362,907
| New | +$13.9M |
|
539
Vanguard Dividend Appreciation ETF
VIG
$114B
| $13.8M | 0.04% |
135,400
-28,175
| -17% | -$2.87M |
|
|
DNB
540
DELISTED
Dun & Bradstreet
DNB
| $13.7M | 0.04% |
111,925
+25,709
| +30% | +$3.13M |
|
541
Medpace
MEDP
$17.3B
| $13.7M | 0.04% |
319,171
+196,841
| +161% | +$7.95M |
|
542
BlackLine
BL
$1.85B
| $13.7M | 0.04% |
315,855
-88,354
| -22% | -$3.73M |
|
543
Check Point Software Technologies
CHKP
$13.3B
| $13.7M | 0.04% |
+140,400
| New | +$13.9M |
|
544
Varonis Systems
VRNS
$4.74B
| $13.7M | 0.04% |
551,331
+406,392
| +280% | +$9.74M |
|
545
PUT
Exelon
EXC
$45.1B
| $13.6M | 0.04% |
448,780
-171,044
| -28% | -$4.9M |
|
546
Edwards Lifesciences
EW
$51.8B
| $13.6M | 0.04% |
279,837
-1,007,595
| -78% | -$47M |
|
547
PUT
CME Group
CME
$98.9B
| $13.6M | 0.04% |
82,800
+77,800
| +1,556% | +$12.7M |
|
548
Performance Food Group
PFGC
$16.5B
| $13.6M | 0.04% |
369,519
-64,969
| -15% | -$2.2M |
|
549
HCA Healthcare
HCA
$92.9B
| $13.5M | 0.04% |
132,032
-122,374
| -48% | -$12.4M |
|
|
FLIR
550
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $13.5M | 0.04% |
+260,581
| New | +$13.9M |
|
Similar funds
John Overdeck's Q2 2018 Portfolio in Review
As of Q2 2018, John Overdeck held 3,907 positions worth $33.5B, up 12% from $30B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
John Overdeck deployed $2.27B of net new capital in Q2 2018, opening 829 new positions and adding to 1,295 existing holdings. Its largest new stake was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Booking.com, an estimated $173M trimmed.
- John Overdeck's largest Q2 2018 buy was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
- John Overdeck added most to Abiomed Inc in Q2 2018, an estimated $138M increase.
- John Overdeck's biggest Q2 2018 reduction was Booking.com, cutting an estimated $173M.
- John Overdeck fully exited Pfizer in Q2 2018, selling an estimated $159M.
- John Overdeck's ten largest holdings make up 5.6% of its $33.5B portfolio in Q2 2018.
- John Overdeck opened 829 new positions and closed 662 in Q2 2018.
- John Overdeck's portfolio value rose 12% quarter-over-quarter to $33.5B.
Based on Two Sigma Investments's 13F filing for Q2 2018, filed 14 Aug 2018.